MedTrace Logo

Management of Infants Born to Group B Streptococcus Positive Mothers.

NCT00716781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16394

Last updated 2008-07-16

No results posted yet for this study

Summary

Intrapartum antibiotic prophylaxis has greatly decreased but not abolished early-onset neonatal sepsis caused by GBS. According to current recommendations, the evaluation of infants at risk for GBS sepsis should include a complete blood count (CBC), WBC differential, a blood culture (BC) and a period of observation. The usefulness of CBC and BC in the evaluation process is not firmly established.

Conditions

  • Group B Streptococcus
  • Sepsis
  • Infant, Newborn

Sponsors & Collaborators

  • Friuli Venezia Giulia Regional Health Authority

    collaborator UNKNOWN

  • IRCCS Burlo Garofolo

    lead OTHER

Principal Investigators

  • Sergio De Marini, MD · IRCCS Burlo Garofolo, Trieste, Italy

  • Luigi Cantoni, MD · San Daniele Hospital, San Daniele, Italy

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2006-06-30
Completion
2006-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00716781 on ClinicalTrials.gov